Now showing items 1-1 of 1
Biosimilars in the French and Polish System: Chosen Aspects of Reimbursement and Access
(Wydawnictwo Uniwersytetu Łódzkiego, 2020-06-23)
The EU approved the first biosimilar drug in 2006. By 2017, the EU had authorized the highest number of biosimilars worldwide, acquiring considerable experience in their use and safety. In May 2019, the European Medicines ...